China and the global stem cell bioeconomy: an emerging political strategy?

Author： Salter Brian   Cooper Melinda   Dickins Amanda  

Publisher： Future Medicine

ISSN： 1746-0751

Source： Regenerative Medicine, Vol.1, Iss.5, 2006-09, pp. : 671-683

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 80, Iss. 4, 2015-10 ,pp. : 618-629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Busulfan dosing algorithm and sampling strategy in stem cell transplantation patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 306-5251, Iss. 4, 2015-10 ,pp. : 618-629

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pediatric hematopoietic stem cell transplantation in China: Data and trends during 1998–2012

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 5, 2015-08 ,pp. : 563-570

John Wiley & Sons Inc

Access to resources Recommend Favorite

Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 275-283

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical comparison of weight‐ and age‐based strategy of dose administration in children receiving intravenous busulfan for hematopoietic stem cell transplantation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 3, 2015-05 ,pp. : 307-315

John Wiley & Sons Inc

Access to resources Recommend Favorite